CiiTA is the nationally recognized and neutral thought leader on the 340B Drug Pricing Program, with a specialty focus on the interaction of Medicaid rebates and 340B. We collaborate with pharmaceutical manufacturers, plans, and covered entities to address the duplicate discount challenges of 340B compliance. Utilizing our proprietary technology and processes, we work across the 340B Program to help realize results and ensure compliance.
Find us at the event
- Stand number